Table: Rohto -Q1 group results

Rohto Pharmaceutical

11/08/2020 07:00

Aug 11 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               38.64               41.91           183.00    
                   (-7.8 pct)          (+3.1 pct)       (-2.8 pct)  
  Operating            3.88                3.86            21.80    
                   (+0.4 pct)          (-23.7 pct)      (-5.6 pct)  
  Recurring            4.11                3.92            22.10    
                   (+4.6 pct)          (-25.8 pct)      (-2.8 pct)  
  Net                  1.94                2.22            14.00    
                   (-12.6 pct)         (-35.5 pct)      (-9.2 pct)  
  EPS               16.99 yen           19.46 yen       122.73 yen  
  EPS Diluted       16.94 yen           19.38 yen                   
  Ann Div                               26.00 yen        27.00 yen  
  -Q2 div                               13.00 yen        13.00 yen  
  -Q4 div                               13.00 yen        14.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T